Skip to main content
Clinical Trials/NCT03942952
NCT03942952
Completed
Not Applicable

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

University of Texas Southwestern Medical Center1 site in 1 country49 target enrollmentOctober 22, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis, Relapsing-Remitting
Sponsor
University of Texas Southwestern Medical Center
Enrollment
49
Locations
1
Primary Endpoint
Change i Score of D-KEFS Letter and Category Fluency
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Central Nervous System (CNS) demyelinating conditions include multiple sclerosis (MS), Acute Disseminated Encephalomyelitis (ADEM), Neuromyelitis Optica Spectrum Disorder (NMOSD), Optic Neuritis (ON) and Transverse Myelitis (TM). The symptoms of these conditions are quite variable from patient to patient, but can include motor, sensory, visual, gait and cognitive changes. Conventional MRI can be used to look for new anatomic changes, but fails to measure underlying biochemical changes in brain tissue. The purposes of this study are to identify the biologic and anatomic correlations between cognitive profiles and disease activity using MRI imaging techniques.

Detailed Description

Pediatric patients (age 12 to 21 inclusive) with a diagnosis of multiple sclerosis, ADEM, anti-MOG mediated demyelinating disease as well as healthy controls will be recruited to undergo clinical testing. The study visits will include neuropsychological testing, optical coherence tomography (OCT) and MRI on both the 3T and 7T magnet. Subjects will be asked to undergo two study visits separated by 12 months to 18 months. Each study visit will have the same neuropsychological, OCT, and research MRI examinations.

Registry
clinicaltrials.gov
Start Date
October 22, 2019
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Benjamin Greenberg

Professor

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Multiple Sclerosis , ADEM, anti-MOG antibody associated CNS demyelination
  • Age 12 to 21 inclusive at time of enrollment
  • Ability of parent or legal guardian to provide informed consent if participant is under
  • Ability of patients age 12-17 to give assent
  • Completion of the signed HIPPA authorization form by a parent or legal guardian or by participants (18 years of age).

Exclusion Criteria

  • Known history of traumatic brain injury that required medical care
  • Non-English speaking (based on standardized neuropsychological testing and questionnaires)
  • Claustrophobic, the presence of metallic braces, implants or medical devices that are unsafe at 3T or 7T and/or interfere with the MRI/MRS signals

Outcomes

Primary Outcomes

Change i Score of D-KEFS Letter and Category Fluency

Time Frame: 10-14 months

Verbal Fluency

Change in Score of Reading Fluency

Time Frame: 10-14 months

Reading Speed

Change in Score of Calculation

Time Frame: 10-14 months

Math Calculation Skills

MRI Brain without contrast

Time Frame: 10-14 months

7T MRI

Change in Score of Beery-Buktencia Developmental Test of Visual-Motor Integration, Sixth Edition (VMI-6)

Time Frame: 10-14 months

Visual-Motor Integration

Change in Score of Word Attack

Time Frame: 10-14 months

Phoneme/Grapheme Knowledge

Change in Score of WISC-V or WAIS-IV Digits Backward

Time Frame: 10-14 months

Working Memory

Change in Score of Woodcock-Johnson Tests of Achievement Letter Word identification

Time Frame: 10-14 months

Basic Reading Skill

Change in Score of Grooved Pegboard

Time Frame: 10-14 months

Bilateral Fine Motor Speed and Dexterity

Change in Score of Symbol Digit Modalities (SDMT)- Oral Version

Time Frame: 10-14 months

Processing Speed

Change in Score of Wechsler Adult Intelligence Scale-Fourth edition (WAIS-IV) Digits Forward

Time Frame: 10-14 months

Simple Auditory Attention

Change in Score of California Verbal Learning Test- Children's Version (CVLT-C) or California Verbal Learning Test-Second Edition (CVLT-II)

Time Frame: 10-14 months

Verbal Learning and Memory

Change in Score of WASI-II

Time Frame: 10-14 months

Estimate of IQ

Change in Score of Conners Continuous Performance Test 3rd Edition

Time Frame: 10-14 months

Sustained Attention and Behavioral Inhibition

Change in Score of Delis-Kaplan Executive Function System (D-KEFS) Color

Time Frame: 10-14 months

Executive Functioning

Change in Score of Word Interference Test (CWIT)

Time Frame: 10-14 months

Executive Functioning

Change in Score of Wechsler Intelligence Scale for Children-5th edition (WISCV)

Time Frame: 10-14 months

Simple Auditory Attention

Change in Score of Trail Making Test, Part A and B

Time Frame: 10-14 months

Simple and complex Attention

Change in Score of Math Fluency

Time Frame: 10-14 months

Math Speed

Secondary Outcomes

  • Change in score of Hauser Ambulation Index(10-14 months)
  • Change in PROMIS Pain score(10-14 months)
  • Change in score of Multiple Sclerosis Functional Capacity (MSFC)(10-14 months)
  • Change in Examination of Optical Coherence Tomography(10-14 months)
  • Change in PROMIS Upper extremity movement score(10-14 months)
  • Change in score of 25 foot timed walk(10-14 months)
  • Change in score of 6 minute timed walk(10-14 months)
  • Change in PROMIS Mobility score(10-14 months)
  • Change in PROMIS Peer relationship score(10-14 months)
  • Change in PROMIS Stress score(10-14 months)
  • Change in score of Modified Rankin Scale(10-14 months)

Study Sites (1)

Loading locations...

Similar Trials